333 related articles for article (PubMed ID: 11328451)
1. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
[TBL] [Abstract][Full Text] [Related]
2. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
Dakine N; Oliver C; Grino M
J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
[TBL] [Abstract][Full Text] [Related]
3. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR
J Neuroendocrinol; 2001 Jun; 13(6):561-6. PubMed ID: 11412343
[TBL] [Abstract][Full Text] [Related]
4. Centrally administered orexin/hypocretin activates HPA axis in rats.
Kuru M; Ueta Y; Serino R; Nakazato M; Yamamoto Y; Shibuya I; Yamashita H
Neuroreport; 2000 Jun; 11(9):1977-80. PubMed ID: 10884055
[TBL] [Abstract][Full Text] [Related]
5. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
[TBL] [Abstract][Full Text] [Related]
6. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
[TBL] [Abstract][Full Text] [Related]
8. Effects of orexins on the hypothalamic-pituitary-adrenal system.
Jászberényi M; Bujdosó E; Pataki I; Telegdy G
J Neuroendocrinol; 2000 Dec; 12(12):1174-8. PubMed ID: 11106974
[TBL] [Abstract][Full Text] [Related]
9. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
Walker CD; Tankosic P; Tilders FJ; Burlet A
J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
[TBL] [Abstract][Full Text] [Related]
10. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
[TBL] [Abstract][Full Text] [Related]
11. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
12. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
Ogilvie KM; Rivier C
Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
[TBL] [Abstract][Full Text] [Related]
15. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates.
Samson WK; Taylor MM; Follwell M; Ferguson AV
Regul Pept; 2002 Mar; 104(1-3):97-103. PubMed ID: 11830283
[TBL] [Abstract][Full Text] [Related]
16. Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors.
Jessop DS; Renshaw D; Larsen PJ; Chowdrey HS; Harbuz MS
Stress; 2000 May; 3(3):209-20. PubMed ID: 10938582
[TBL] [Abstract][Full Text] [Related]
17. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
Schwartz MW; Strack AM; Dallman MF
Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
[TBL] [Abstract][Full Text] [Related]
18. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress.
Shepard JD; Barron KW; Myers DA
Brain Res; 2003 Feb; 963(1-2):203-13. PubMed ID: 12560126
[TBL] [Abstract][Full Text] [Related]
19. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats.
Brunton PJ; Russell JA
J Neuroendocrinol; 2003 Jul; 15(7):633-7. PubMed ID: 12787047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
